Abbott Offers Concessions in EU Review of Solvay Transaction

Abbott Laboratories offered concessions to the European Union in a bid to win approval for its $6.8 billion purchase of Solvay SA’s drug unit after regulators had concerns about a diagnostic test.
DailyHerald